These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4346780)

  • 21. The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism.
    Mitchell A; Rushentsova U; Siffert W; Philipp T; Wenzel RR
    Clin Pharmacol Ther; 2006 Mar; 79(3):274-81. PubMed ID: 16513451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of extra- and intracellular electrolyte metabolism on vascular reactivity to norepinephrine and angiotensin in patients with hyperthyreosis and in normotensives with familial history of hypertension].
    Wessels F; Losse H
    Arztl Forsch; 1970 Dec; 24(12):349-57. PubMed ID: 4321787
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanism of the antihypertensive effect of 1-Sar-8-Ala-angiotensin II during the acute phase of experimental renal hypertension.
    Pals DT; Fulton RW
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):20-30. PubMed ID: 4355711
    [No Abstract]   [Full Text] [Related]  

  • 24. Interaction between the natriuretic effects of renal perfusion pressure and the antinatriuretic effects of angiotensin and aldosterone in control of sodium excretion.
    Young DB; Pan YJ
    J Physiol (Paris); 1984; 79(6):511-7. PubMed ID: 6399318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the renin-system in normo- and hypertension. Effect of angiotensin-inhibitor (1-sar-8-ala-angiotensin II) on the blood pressure of conscious or anaesthetized normal, nephrectomized and renal hypertensive rats.
    Bing J; Nielsen K
    Acta Pathol Microbiol Scand A; 1973 May; 81(3):254-62. PubMed ID: 4358386
    [No Abstract]   [Full Text] [Related]  

  • 26. The long-term effectiveness of methyldopa in hypertension.
    Okun R; Roth SE; Gordon A; Maxwell MH
    Calif Med; 1966 Jan; 104(1):46-50. PubMed ID: 5909253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Angiotensin II antagonists].
    Tikkanen I; Tikkanen T
    Duodecim; 1995; 111(18):1733-5. PubMed ID: 9340266
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical studies on the etiology of essential hypertension. Pressor response to noradrenaline].
    Ueda T
    Sapporo Igaku Zasshi; 1965; 27(1):20-31. PubMed ID: 4286748
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison of chlorthalidone-reserpine and hydrochlorothiazide-methyldopa as step 2 therapy for hypertension.
    Channick BJ; Kessler WB; Marks AD; Adlin EV
    Clin Ther; 1981; 4(3):175-83. PubMed ID: 7307035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandins and the regulation of blood pressure.
    McGiff JC; Vane JR
    Kidney Int Suppl; 1975 Sep; ():S262-70. PubMed ID: 1059806
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dopegit in the treatment of hypertensive disease].
    Erina EV; Pershakova LP; Vasil'eva LA
    Kardiologiia; 1971 May; 11(5):96-104. PubMed ID: 5126325
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of rabbit antibodies against angiotensin-II on the pressor response to angiotensin-II and renal hypertension in the rat.
    Hedwall PR
    Br J Pharmacol; 1968 Nov; 34(3):623-9. PubMed ID: 4302379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pressor and subpressor angiotensin II administration. Two experimental models of hypertension.
    Simon G; Abraham G; Cserep G
    Am J Hypertens; 1995 Jun; 8(6):645-50. PubMed ID: 7662251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dopegyt (alpha-methyldopa) in arterial hypertension].
    Kedra M; Koziara Z
    Pol Tyg Lek; 1971 Jun; 26(25):963-5. PubMed ID: 5564519
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of exogenous angiotensin II on blood pressure in experimental nephrogenic and neurogenic-interoreceptive hypertension of rats].
    Nitschkoff S; Gnüchtel U; Jonas P; Wolnik L
    Dtsch Gesundheitsw; 1969 Dec; 24(51):2401-8. PubMed ID: 4316623
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diazoxide: new way in treatment of hypertension].
    Wijdeveld P; Koene R
    Ned Tijdschr Geneeskd; 1975 Mar; 119(11):421-30. PubMed ID: 1161062
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of vascular hypertrophy in early and chronic renovascular hypertension.
    Mistry M; Bing RF; Swales JD; Thurston H
    J Hypertens Suppl; 1983 Dec; 1(2):79-81. PubMed ID: 6599501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of severe hypertension with Catapres (St 155). A comparative study of the effect of catapres and methyldopa in a series of hypertensive outpatients (WHO stage 3).
    Becker-Christensen F; Bang HO; Ditzel J
    Acta Med Scand; 1971; 190(1-2):21-6. PubMed ID: 5099124
    [No Abstract]   [Full Text] [Related]  

  • 39. [The pressure response to angiotensin and to noradrenaline in normal pregnancy and in the gestosic syndrome].
    Morandini G; Mangioni C
    Minerva Med; 1967 Apr; 58(34):1546-52. PubMed ID: 4290789
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mineralocorticoid-induced changes of vascular reactivity to noradrenaline and angiotensin II in baboons].
    Wallrabe D; Gnüchtel U; Bodewei R; Schönfelder G
    Cor Vasa; 1983; 25(2):154-8. PubMed ID: 6872547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.